scholarly journals Home dialysis in french speaking countries in 2020 (RDPLF database)

2021 ◽  
Vol 4 (1) ◽  
pp. 55-70
Author(s):  
Christian Verger ◽  
Ghislaine Veniez ◽  
Marie-Christine Padernoz ◽  
Emmanuel Fabre

The RDPLF collects the main peritoneal dialysis data from centers in French-speaking countires and, since 2012, home hemodialysis (HHD) data. This article presents a summary of the main results in the RDPLF in 2020. It highlights important differences in the practices and patient profiles between French-speaking countries. Mortality in patients with clinical symptoms of COVID-19 varied from 15 to 63% depending on the country. A slight drop in the incidence rate for peritoneal dialysis in 2020 was observed when the Covid-19 pandemic should have favored a dialysis treatment at home. In patients with HHD, daily hemodialysis five days a week, at a low flow rate of dialysate, is predominant in the new centers and sometimes begins to appear as a mode of transition which allows to maintain at home patients who cannot anymore be treated by PD. In HHD, the use of a central catheter is frequent in Belgium while this is exceptional in France. Likewise, in France, puncture of an arteriovenous fistula remains classic, while in Belgium the Buttonhole technique is widely preferred. We did not observe COVID-19 mortality in HHD in 2020 but only 47% of HDD patients are included in the RDPLF while 98% of PD patients are included.

2021 ◽  
Vol 4 (3) ◽  
pp. 227-237
Author(s):  
Christian Verger ◽  
Emmanuel Fabre ◽  
Pierre-Yves Durand ◽  
Jacques Chanliau ◽  
Isabelle Vernier ◽  
...  

Aims of the study: to assess the frequency of symptomatic Covid-19 in home dialysis patients and its influence on the number of patients treated at home in dialysis units of centers included in the French-speaking peritoneal and home hemodialysis Registry (RDPLF). Focus is placed on patients treated by peritoneal dialysis (PD) in mainland France. Results: in home hemodialysis (HHD)the incidence is 6% in Belgium and 4.8% in mainland France. On peritoneal dialysis it is 10.6% in Belgium, 6.7% in mainland France, 10.8% in Morocco and 11.5% in Tunisia. Lethality is less than 5% in HHD and between 8.4% and 42.7% in PD depending on age and associated comorbidities. In France, the percentage of patients who have had symptomatic Covid-19 is lower on home dialysis, all methods combined. Nevertheless, among the home methods, the higher frequencies and severities are observed in mainland France in home assisted PD: these are the oldest and most co-morbid patients. Transfers from PD to in center hemodialysis have increased during Covid-19 pandemic while the number of transplants has decreased. Conclusion: if the drop in the number of transplants can be explained by a reduced availability of operating theaters and surgical teams during a pandemic period, it is paradoxical that the prescription of home dialysis, which should be supposed to limit the risk of contagion, has decreased. More investigation should be performed to understand this paradox.  


2021 ◽  
Vol 4 (3) ◽  
Author(s):  
Max Dratwa ◽  
Christian Verger

We are pleased to announce with this new issue of the Bulletin de la Dialysis à Domicile (BDD), the bilingual journal of the RDPLF, the recent signing of a partnership agreement between the International Society of Peritoneal Dialysis (ISPD) and the RDPLF. The RDPLF now officially ensures the French translation of international open access recommendations published by the ISPD. The goal is to allow better distribution to French-speaking professionals who have difficulty accessing English-language medical literature.   In addition a webinar in French will be organized on an annual basis, in collaboration with the ISPD which will ensure logistics management. The dates will be communicated later. We warmly thank Professor Xueqing Yu, President of ISPD, and the members of the ISPD Board, for this agreement which will promote communication between health professionals who speak different languages. Max Dratwa, Christian Verger and the editorial committee.   Contents of this issue: - Assessment of Patient Experience of Care in Home Dialysis around the World: Enhancing the Patient’s Voice in Home Dialysis Care and Research - Narrative interviews to assess quality of life in Peritoneal Dialysis -Chylous peritonitis in peritoneal dialysis - Peritoneal dialysis in indigenous Australians - French translation of ISPD Recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention - Home dialysis and Covid-19 in French speaking countries (RDPLF data-base) - Literature review (in French only) by the Young Nephrologists Club      


2019 ◽  
Vol 2 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Christian Verger ◽  
Emmanuel Fabre ◽  
Ghislaine Veniez ◽  
Marie Christine Padernoz

The RDPLF was created in 1986 and collects the main data of peritoneal dialysis of French patients and of various French-speaking countries. The database is structured in several modules: a compulsory core module including a follow-up of comorbidities, assistance, infections, survival, transplantation, and optional modules following more specific aspects: nursing, catheter, anemia, nutrition, heart failure. In addition, since 2012 patients treated at home in hemodialysis are also followed. This article presents a summary of the main characteristics of patients in the RDPLF in 2018. It highlights important differences in practices and patient profiles between francophone countries. Daily low dialysate flow rate hemodialysis is predominant in the new centers and sometimes begins to appear as a transitional mode that allows home maintenance for patients who cannot continue on peritoneal dialysis.


1992 ◽  
Vol 12 (4) ◽  
pp. 365-368 ◽  
Author(s):  
Alexander C. Grant ◽  
R. Stuart C. Rodger ◽  
Catherine A. Howie ◽  
Brian J.R. Junor ◽  
J. Douglas Briggs ◽  
...  

Objective To audit the outcome of patients treated at home by hemodialysis and continuous ambulatory peritoneal dialysis (CAPD). Design Retrospective comparison of nondiabetic hemodialysis patients with age and sex-matched nondiabetic patients treated by CAPD. Setting Renal Units, Stobhill General Hospital and Western Infirmary, Glasgow, providing the home dialysis service for the West of Scotland. Patients Between 1982 and 1988, 139 hemodialysis patients starting treatment at home, compared with 139 matched patients starting CAPD over the same time period. Main Outcome Measures Patient characteristics and cardiovascular risk factors at the start of home treatment. Patient and technique survival with both forms of dialysis. Results Patients selected for home hemodialysis were less likely to be smokers (p<0.02) and to have electrocardiographic evidence of ischemia or left ventricular hypertrophy (p<0.05) than patients treated by CAPD. Patient survival and technique survival (excluding death and renal transplantation) at 3 years were 93.8% versus 86.2% (p<0.05) and 94.2% versus 80.8% (p<0.04) for hemodialysis and CAPD, respectively. Cardiovascular events were responsible for the majority of deaths in both groups, but there was a greater proportion of deaths from other causes in patients treated by CAPD. There was no significant difference in the transplantation rate between the two treatment groups. Conclusions Home dialysis is an effective method of renal replacement treatment for patients with end-stage renal disease. The results of hemodialysis are superior to CAPD, but this may be partly due to selection bias.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
I-En Lin ◽  
Hao-Ting Chiang

Abstract When compared with conventional kidney hemodialysis, peritoneal dialysis (PD) has advantages such as maintaining stable physiological blood status and blood pressure, alleviating anemia, and improving mobility, which make it an ideal method for at-home (even on the road) dialysis treatment. However, a serious drawback of PD is the potential for infection of the abdominal lining (peritonitis), which can discourage people from using PD. Since PD can involve up to 4–5 fluid exchanges per day that require connection and disconnection of a tube to a catheter, there can be a substantial risk of infection. This infection risk creates a barrier to the use of PD and prevents people from enjoying the benefits of convenience and portability that PD can provide. This study proposes an assistive holder for PD patients that helps reduce the possibility of contamination during connection and disconnection of dialysis solution exchange bags. This PD assistive holder is low-cost, lightweight, and disposable. The holder is compatible with existing PD procedures and it can be used by touch only, for people with impaired vision. The PD assistive holder enables patients to care for themselves at home and improves the functionality and portability of standard PD systems.


2018 ◽  
Vol 1 (3) ◽  
pp. 99-103
Author(s):  
Alain Meyrier

The first publication in 1960 on maintenance hemodialysis was followed in 1963 by some reports on dialysis in the home. The introduction of proportioning pumps and concentrated electrolyte solutions led to developing single-patient machines and safety devices that made home hemodialysis possible.  It was demonstrated in 1964 that home hemodialysis can be done overnight, unattended. This led to a steady rise in the number of patients treated at home. The percentage in France was ≈20% by the end of the seventies, out of a total of  ≈ 6 000.  The decline began when Public Health authorities authorized a program of ‘’limited – care’’ units.  A loophole in the regulations led to a massive transfer of patients to these units and a rapid decline of home HD. The revival can be dated to 2012 with the development of disposable dialysate bags that make low flow daily home HD feasible. Efficacy and tolerability are such that the total number of patients treated at home rose from 307 in 2014 to 374 in 2016, owing to those on daily hemodialysis -  an increase from 55 in 2014 to 374 in 2016 and 448 by the end of 2018. Currently, ≈46 000 patients are hemodialyzed in France.   The % of those treated at home is very low but the trend is to a steady increase.


2020 ◽  
Vol 3 (3) ◽  
pp. 169-176
Author(s):  
Christian Verger ◽  
Emmanuel Fabre

A renewed interest in home hemodialysis has emerged in recent years, favored by the availability of new dialysis machines and encouraging publication about  daily hemodialysis. Since 2013, the RDPLF has become a home dialysis registry that records the data of patients treated with peritoneal dialysis and those treated with home hemodialysis, all techniques combined. Nine Belgian centers and fifty seven French centers communicate information about their patients treated by hemodialysis at home. In the RDPLF centers, 56% of Belgian home hemodialysis patients are treated with daily hemodialysis, in France 83% of home patients are on daily dialysis. This French difference however is not representative of the whole country but can be explained through recruitment of new centers already involved in peritoneal dialysis and convinced by the interest of continuaous daily treatment. In both countries, 13% of home hemodialysis patients have been previously treated with peritoneal dialysis with an interim period of in-center hemodialysis or transplantation. The median duration of in center hemodialysis is 10 months with extremes ranging from 2 months to 25 years. PD patients treated secondarily in home hemodialysis are mainly young, non-diabetic and independent patients. Early information in patients who have a risk of peritoneal dialysis failure, and the provision of materials allowing both techniques would reduce or abolish a transient transfer to in center hemodialysis  and would ensure home care in patients who prefer.


2020 ◽  
Vol 3 (4) ◽  
pp. 213-226
Author(s):  
Cécile Couchoud ◽  
Christian Verger

In France all patients treated with dialysis are registered in the REIN registry  (Epidemiology and Information Network in Nephrology) ; in addition  the RDPLF (French Language Peritoneal Dialysis Registry) monitors patients treated at home in French-speaking regions and countries. Asymptomatic patients with a positive SARS-CoV2 test were excluded :  the study focused only on patients with symptomatic COVID-19 disease. Data from REIN and RDPLF were used. In total, 3,541 patients were declared symptomatic with COVID-19. The proportion of patients with symptomatic SAR-coV2 infection was 4.9% in patients treated at home by peritoneal dialysis or hemodialysis and 8.0% in those treated in a dialysis unit. After adjustment for age and comorbidities, being treated at home was associated with a higher risk of mortality. In conclusion, home treatments could represent a solution for preventing the risk of contamination during the circulation of the virus. On the other hand, the risk of mortality in symptomatic patients at home could be linked to a delay in treatment: rigorous remote organization must be implemented so as not to delay the treatment of patients in the event of infection.


2020 ◽  
Vol 32 (1) ◽  
pp. 148-150
Author(s):  
Giuseppe Vanacore ◽  
Antonio Santoro

The National Plan of Chronicity, approved by the Italian State-Regions Conference, refers to the topic of home care, specifying how the fundamental objective of chronic care systems is to keep the sick person at home as much as possible. Currently, home dialysis – both peritoneal and haemodialysis – uses high-quality safe technology systems and allows patients to perform therapy safely at home. ANED wishes to stress that the choice of dialysis treatment, which certainly depends on clinical evaluations, must at the same time consider the psychological and emotional aspects of the patient, the expectations and needs of his life and the social context, aiming at an increasingly personalized and sustainable therapy for patients and the healthcare system.


Sign in / Sign up

Export Citation Format

Share Document